JENNIFER AGRUSA to Protein Kinase Inhibitors
This is a "connection" page, showing publications JENNIFER AGRUSA has written about Protein Kinase Inhibitors.
Connection Strength
0.197
-
Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1882-1887.
Score: 0.156
-
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era. Blood Adv. 2025 Mar 25; 9(6):1356-1365.
Score: 0.042